Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

C Gao, J Jiang, Y Tan, S Chen - Signal transduction and targeted …, 2023 - nature.com
Microglia activation is observed in various neurodegenerative diseases. Recent advances in
single-cell technologies have revealed that these reactive microglia were with high spatial …

Mesenchymal stromal cell therapies for neurodegenerative diseases

NP Staff, DT Jones, W Singer - Mayo Clinic Proceedings, 2019 - Elsevier
Mesenchymal stromal cells are multipotent cells that are being used to treat a variety of
medical conditions. Over the past decade, there has been considerable excitement about …

Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease

M Dani, M Wood, R Mizoguchi, Z Fan, Z Walker… - Brain, 2018 - academic.oup.com
Alzheimer's disease is characterized by the histopathological presence of amyloid-β
plaques and tau-containing neurofibrillary tangles. Microglial activation is also a recognized …

Multiple system atrophy: an oligodendroglioneural synucleinopathy

KA Jellinger - Journal of Alzheimer's Disease, 2018 - content.iospress.com
Multiple system atrophy (MSA) is an orphan, fatal, adult-onset neurodegenerative disorder of
uncertain etiology that is clinically characterized by various combinations of parkinsonism …

Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms

N Stefanova, GK Wenning - Nature Reviews Neuroscience, 2023 - nature.com
Multiple system atrophy (MSA) is a rare oligodendroglial α-synucleinopathy characterized by
neurodegeneration in striatonigral and olivopontocerebellar regions and autonomic brain …

Microglia: Multiple roles in surveillance, circuit shaping, and response to injury

EE Benarroch - Neurology, 2013 - AAN Enterprises
Microglial cells are the immune cells in the CNS and represent approximately 10% of the
total brain cell population. Their morphologic characterization by Pio del Rio-Hortega was …

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

E Croisier, LB Moran, DT Dexter, RKB Pearce… - Journal of …, 2005 - Springer
Background The role of both microglial activation and alpha-synuclein deposition in
Parkinson's disease remain unclear. We have tested the hypothesis that if microglia play a …

The neuropathology, pathophysiology and genetics of multiple system atrophy

Z Ahmed, YT Asi, A Sailer, AJ Lees… - Neuropathology and …, 2012 - Wiley Online Library
Z. Ahmed, YT Asi, A. Sailer, AJ Lees, H. Houlden, T. Revesz and JL Holton (2012)
Neuropathology and Applied Neurobiology38, 4–24 The neuropathology, pathophysiology …

[HTML][HTML] Glia and alpha-synuclein in neurodegeneration: A complex interaction

D Brück, GK Wenning, N Stefanova, L Fellner - Neurobiology of disease, 2016 - Elsevier
Abstract α-Synucleinopathies (ASP) comprise adult-onset, progressive neurodegenerative
disorders such as Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple …

Microglia and neuroprotection: from in vitro studies to therapeutic applications

E Polazzi, B Monti - Progress in neurobiology, 2010 - Elsevier
Microglia are the main immune cells in the brain, playing a role in both physiological and
pathological conditions. Microglial involvement in neurodegenerative diseases is well …